Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sonoma Pharmaceuticals, Inc. - Common Stock (NQ:SNOA)

4.020 -0.050 (-1.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sonoma Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results
 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
US Stocks Likely To Open Higher After Trump Administration Hints At A Deal With China: 'It Is Prudent To Expect Continued Volatility In The Weeks Ahead,' Says Expert
U.S. stock futures continued rising on Wednesday after a day of strong recovery on Tuesday. Futures of major benchmark indices were higher in premarket. 
Via Benzinga
Topics Government
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
Via ACCESS Newswire
Wondering what's happening in today's after-hours session?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain
Via ACCESS Newswire
Unusual volume stocks are being observed in Tuesday's session.
In today's session, these stocks are experiencing unusual volume. 
Via Chartmill
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
Via ACCESSWIRE
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split. 
Via Benzinga
What's Going On With Sonoma Pharmaceuticals Stock Tuesday?
Sonoma stock is trading higher on Tuesday after the company announced that it secured U.K. regulatory clearance for its key wound care and dermatology products. 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
What's going on in today's after hours session
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
Via Chartmill
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
Via ACCESS Newswire
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
Via ACCESSWIRE
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
Via ACCESSWIRE
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
Via ACCESSWIRE
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
Via ACCESSWIRE
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
Via ACCESSWIRE
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
Via ACCESSWIRE
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
Via ACCESSWIRE
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
Via ACCESSWIRE
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.